LENZ Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Olsson Shawn
LENZ Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Odrich Marc
LENZ Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chevallard Daniel R.
LENZ Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Schimmelpennink Evert B.
LENZ Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Olsson Shawn
LENZ Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Tang Capital Management, LLC(2.8%),Kevin Tang(2.8%), etc.
LENZ Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(7.6%),Versant Ventures VI GP, L.P.(7.6%), etc.
LENZ Therapeutics | 424B3: Prospectus
LENZ Therapeutics | 424B3: Prospectus
LENZ Therapeutics | 10-Q: Q3 2024 Earnings Report
LENZ Therapeutics | 8-K: LENZ Therapeutics Reports Third Quarter 2024 Financial Results
LENZ Therapeutics | 424B3: Prospectus
LENZ Therapeutics | 424B3: Prospectus
LENZ Therapeutics | 8-K: Current report
LENZ Therapeutics | EFFECT: Others
LENZ Therapeutics | 424B3: Prospectus
LENZ Therapeutics | CORRESP: CORRESP
LENZ Therapeutics | UPLOAD: Others
LENZ Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
LENZ Therapeutics | 424B3: Prospectus
No Data